SKAN Group AG (SKAN) - Net Assets
Based on the latest financial reports, SKAN Group AG (SKAN) has net assets worth CHF133.26 Million CHF (≈ $168.48 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF481.08 Million ≈ $608.21 Million USD) and total liabilities (CHF347.81 Million ≈ $439.73 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SKAN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF133.26 Million |
| % of Total Assets | 27.7% |
| Annual Growth Rate | 4.76% |
| 5-Year Change | -23.41% |
| 10-Year Change | 87.25% |
| Growth Volatility | 33.64 |
SKAN Group AG - Net Assets Trend (2012–2025)
This chart illustrates how SKAN Group AG's net assets have evolved over time, based on quarterly financial data. See SKAN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for SKAN Group AG (2012–2025)
The table below shows the annual net assets of SKAN Group AG from 2012 to 2025. For live valuation and market cap data, see SKAN Group AG stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CHF133.26 Million ≈ $168.48 Million |
-34.21% |
| 2024-12-31 | CHF202.56 Million ≈ $256.09 Million |
+14.86% |
| 2023-12-31 | CHF176.36 Million ≈ $222.97 Million |
+6.50% |
| 2022-12-31 | CHF165.59 Million ≈ $209.36 Million |
-4.83% |
| 2021-12-31 | CHF174.01 Million ≈ $219.99 Million |
+110.78% |
| 2020-12-31 | CHF82.55 Million ≈ $104.37 Million |
-26.25% |
| 2019-12-31 | CHF111.93 Million ≈ $141.51 Million |
+19.22% |
| 2018-12-31 | CHF93.89 Million ≈ $118.70 Million |
+8.45% |
| 2017-12-31 | CHF86.57 Million ≈ $109.45 Million |
+21.64% |
| 2016-12-31 | CHF71.17 Million ≈ $89.98 Million |
-6.97% |
| 2015-12-31 | CHF76.50 Million ≈ $96.72 Million |
-11.93% |
| 2014-12-31 | CHF86.87 Million ≈ $109.82 Million |
+4.13% |
| 2013-12-31 | CHF83.42 Million ≈ $105.47 Million |
+14.57% |
| 2012-12-31 | CHF72.81 Million ≈ $92.05 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SKAN Group AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 0.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF11.95 Million | 10.44% |
| Common Stock | CHF225.00K | 0.20% |
| Other Comprehensive Income | CHF102.27 Million | 89.36% |
| Total Equity | CHF114.45 Million | 100.00% |
SKAN Group AG Competitors by Market Cap
The table below lists competitors of SKAN Group AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SUPERLOOP LTD
F:9SL
|
$1.07 Billion |
|
Chengdu Guibao Science Tech
SHE:300019
|
$1.07 Billion |
|
Puuilo Oyj
HE:PUUILO
|
$1.07 Billion |
|
Community Trust Bancorp Inc
NASDAQ:CTBI
|
$1.07 Billion |
|
Alvotech
IC:ALVO
|
$1.07 Billion |
|
Siam Global House Public Company Limited
BK:GLOBAL
|
$1.07 Billion |
|
International General Insurance Holdings Ltd
NASDAQ:IGIC
|
$1.07 Billion |
|
Tompkins Financial Corporation
NYSE MKT:TMP
|
$1.07 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SKAN Group AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 196,159,000 to 114,449,000, a change of -81,710,000 (-41.7%).
- Net income of 16,274,000 contributed positively to equity growth.
- Dividend payments of 8,993,000 reduced retained earnings.
- Other comprehensive income increased equity by 102,271,000.
- Other factors decreased equity by 191,262,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF16.27 Million | +14.22% |
| Dividends Paid | CHF8.99 Million | -7.86% |
| Other Comprehensive Income | CHF102.27 Million | +89.36% |
| Other Changes | CHF-191.26 Million | -167.12% |
| Total Change | CHF- | -41.65% |
Book Value vs Market Value Analysis
This analysis compares SKAN Group AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.58x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 5.77x to 9.58x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | CHF8.45 | CHF48.75 | x |
| 2013-12-31 | CHF9.14 | CHF48.75 | x |
| 2014-12-31 | CHF8.30 | CHF48.75 | x |
| 2015-12-31 | CHF7.39 | CHF48.75 | x |
| 2016-12-31 | CHF6.96 | CHF48.75 | x |
| 2017-12-31 | CHF8.44 | CHF48.75 | x |
| 2018-12-31 | CHF9.11 | CHF48.75 | x |
| 2019-12-31 | CHF10.69 | CHF48.75 | x |
| 2020-12-31 | CHF3.98 | CHF48.75 | x |
| 2021-12-31 | CHF12.63 | CHF48.75 | x |
| 2022-12-31 | CHF7.00 | CHF48.75 | x |
| 2023-12-31 | CHF7.53 | CHF48.75 | x |
| 2024-12-31 | CHF8.72 | CHF48.75 | x |
| 2025-12-31 | CHF5.09 | CHF48.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SKAN Group AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.22%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.88%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 4.20x
- Recent ROE (14.22%) is above the historical average (12.72%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 4.84% | 81.65% | 0.06x | 1.00x | CHF-3.75 Million |
| 2013 | 2.69% | 72.37% | 0.04x | 1.00x | CHF-6.09 Million |
| 2014 | 5.16% | 79.09% | 0.06x | 1.02x | CHF-4.20 Million |
| 2015 | 24.12% | 91.03% | 0.26x | 1.01x | CHF10.80 Million |
| 2016 | 22.44% | 103.67% | 0.21x | 1.01x | CHF8.85 Million |
| 2017 | 17.56% | 780.39% | 0.02x | 1.01x | CHF6.54 Million |
| 2018 | 6.14% | 201.85% | 0.03x | 1.03x | CHF-3.63 Million |
| 2019 | 16.04% | 477.85% | 0.03x | 1.01x | CHF6.76 Million |
| 2020 | 10.88% | 2.36% | 0.74x | 6.23x | CHF367.30K |
| 2021 | 6.65% | 4.53% | 0.71x | 2.08x | CHF-5.36 Million |
| 2022 | 12.07% | 6.86% | 0.71x | 2.47x | CHF3.26 Million |
| 2023 | 15.55% | 8.22% | 0.86x | 2.21x | CHF9.39 Million |
| 2024 | 19.78% | 10.74% | 0.94x | 1.96x | CHF19.19 Million |
| 2025 | 14.22% | 4.88% | 0.69x | 4.20x | CHF4.83 Million |
Industry Comparison
This section compares SKAN Group AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,343,744,167
- Average return on equity (ROE) among peers: 13.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SKAN Group AG (SKAN) | CHF133.26 Million | 4.84% | 2.61x | $1.07 Billion |
| Alcon AG (ALC) | $18.82 Billion | -2.82% | 0.47x | $30.03 Billion |
| Coltene Holding AG (CLTN) | $93.15 Million | 14.29% | 1.67x | $291.30 Million |
| Straumann Holding AG (STMN) | $623.50 Million | 28.21% | 0.52x | $13.27 Billion |
| Tecan Group AG (TECN) | $202.93 Million | 24.31% | 0.72x | $1.72 Billion |
| IVF Hartmann Holding AG (VBSN) | $102.89 Million | 15.99% | 0.27x | $336.00 Million |
| Ypsomed Holding AG (YPSN) | $218.00 Million | 3.90% | 0.50x | $3.97 Billion |
About SKAN Group AG
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar f… Read more